18 October 2022

Safety Alerts

Reference: CIR-2022-00000219

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Medical Product Lot recall In-Ka® ureteral balloon dilatation catheter kit

Voluntary removal of one indication from pharmaceutical product Lynparza Tablets 150 mg and 100 mg

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

 

Supporting Documents:

In-Ka ureteral balloon dilatation catheter kit.pdf:

View Document

Lynparza Tablets 150 mg and 100 mg تعميم اداري.pdf ----.pdf:

View Document